Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.

Onken JE, Greer PK, Calingaert B, Hale LP.

Clin Immunol. 2008 Mar;126(3):345-52. Epub 2007 Dec 21.

PMID:
18160345
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

Banks C, Bateman A, Payne R, Johnson P, Sheron N.

J Pathol. 2003 Jan;199(1):28-35.

PMID:
12474223
[PubMed - indexed for MEDLINE]
3.

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A.

Clin Exp Immunol. 1993 Oct;94(1):174-81.

PMID:
8403503
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans.

Barth H, Guseo A, Klein R.

Eur J Med Res. 2005 Aug 17;10(8):325-31.

PMID:
16131473
[PubMed - indexed for MEDLINE]
5.

Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.

Docena G, Rovedatti L, Kruidenier L, Fanning A, Leakey NA, Knowles CH, Lee K, Shanahan F, Nally K, McLean PG, Di Sabatino A, MacDonald TT.

Clin Exp Immunol. 2010 Oct;162(1):108-15. doi: 10.1111/j.1365-2249.2010.04203.x. Epub 2010 Aug 20.

PMID:
20731675
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.

Matsuda R, Koide T, Tokoro C, Yamamoto T, Godai T, Morohashi T, Fujita Y, Takahashi D, Kawana I, Suzuki S, Umemura S.

Inflamm Bowel Dis. 2009 Mar;15(3):328-34. doi: 10.1002/ibd.20759.

PMID:
18942752
[PubMed - indexed for MEDLINE]
7.

Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).

Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG.

Clin Exp Immunol. 1998 Jun;112(3):435-42.

PMID:
9649212
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.

Verdier J, Begue B, Cerf-Bensussan N, Ruemmele FM.

Inflamm Bowel Dis. 2012 Jul;18(7):1260-6. doi: 10.1002/ibd.21905. Epub 2011 Oct 12.

PMID:
21994045
[PubMed - indexed for MEDLINE]
9.

Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.

de Vries HS, Plantinga TS, van Krieken JH, Stienstra R, van Bodegraven AA, Festen EA, Weersma RK, Crusius JB, Linskens RK, Joosten LA, Netea MG, de Jong DJ.

PLoS One. 2009 Nov 12;4(11):e7818. doi: 10.1371/journal.pone.0007818.

PMID:
19915667
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.

Raddatz D, Bockemühl M, Ramadori G.

Eur J Gastroenterol Hepatol. 2005 May;17(5):547-57.

PMID:
15827446
[PubMed - indexed for MEDLINE]
11.

Increased expression of IL-16 in inflammatory bowel disease.

Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S.

Gut. 2001 Mar;48(3):326-32.

PMID:
11171821
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.

Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J.

Cytokine. 2011 Dec;56(3):633-40. doi: 10.1016/j.cyto.2011.08.036. Epub 2011 Sep 25.

PMID:
21945121
[PubMed - indexed for MEDLINE]
13.

Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.

Hale LP, Greer PK, Trinh CT, Gottfried MR.

Clin Immunol. 2005 Aug;116(2):135-42.

PMID:
15936249
[PubMed - indexed for MEDLINE]
14.

Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.

Siddique I, Hasan F, Khan I.

Scand J Gastroenterol. 2009;44(1):56-64. doi: 10.1080/00365520802321253.

PMID:
18785066
[PubMed - indexed for MEDLINE]
15.

Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.

Ina K, Kusugami K, Hosokawa T, Imada A, Shimizu T, Yamaguchi T, Ohsuga M, Kyokane K, Sakai T, Nishio Y, Yokoyama Y, Ando T.

J Gastroenterol Hepatol. 1999 Jan;14(1):46-53.

PMID:
10029277
[PubMed - indexed for MEDLINE]
16.

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.

Isaacs KL, Sartor RB, Haskill S.

Gastroenterology. 1992 Nov;103(5):1587-95.

PMID:
1426879
[PubMed - indexed for MEDLINE]
17.

Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Reddy KP, Markowitz JE, Ruchelli ED, Baldassano RN, Brown KA.

Dig Dis Sci. 2007 Feb;52(2):365-72. Epub 2007 Jan 12.

PMID:
17219072
[PubMed - indexed for MEDLINE]
18.
19.
20.

Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels.

Blokzijl H, Vander Borght S, Bok LI, Libbrecht L, Geuken M, van den Heuvel FA, Dijkstra G, Roskams TA, Moshage H, Jansen PL, Faber KN.

Inflamm Bowel Dis. 2007 Jun;13(6):710-20.

PMID:
17262809
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk